BRAF and signet ring cell carcinoma: Ogino et al[7] examined BRAF mutation and KRAS mutation in colorectal carcinoma with signet-ring cell component, and did not identify KRAS mutation in any of the 8 signet-ring cell carcinoma cases, all mutations were seen in 33% of cases that had <50% signet-ring cells.